Effect of an herbal supplement containing Cinnamon, Cumin and Phyllanthus emblica ?on inflammatory response in type II diabetes

?Effect of an herbal supplement containing Cinnamon, Cumin and Phyllanthus emblica ?on inflammatory response in type II diabetes

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N142

Enrollment

Registered

2020-06-16

Start date

2020-05-21

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: In addition to the usual treatments for diabetes we treat patients with 6 capsules containing 3 cinnamon plants daily at a dose of 170 milligram, cumin with a dose

Eligibility

Sex/Gender

All

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Fasting blood sugar is equal to or higher than 126 milligram per millileter Taking oral hypoglycemic drugs Consumption of a fixed dose of oral hypoglycemic drugs for at least the last 3 months Eating bread in the diet and not getting celiac disease Lack of kidney failure Lack of type 1 diabetes Lack of acute and chronic inflammatory diseases Lack of malignancy Lack of drug addiction No pregnancy or lactation

Exclusion criteria

Exclusion criteria: Dissatisfaction

Design outcomes

Primary

Measure	Time frame
Cytokine TGF-ß. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine TNF?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IFN-?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IL-17. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Number of Treg cells. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Nitric oxide measurement. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.	—

Measure

Time frame

Cytokine TGF-ß. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine TNF?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IFN-?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IL-17. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Number of Treg cells. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Nitric oxide measurement. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mehdi Salehi

Arak University of Medical Sciences

m.salehi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026